Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Duodenal Neoplasms × Stents × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5 Cholangiocarcinoma 4 Colonic Neoplasms 3 Gallbladder Neoplasms 2 Fistula 2 Esophageal Neoplasms 2 Bile Duct Neoplasms 2 Anastomotic Leak 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Obesity, Morbid 1 Obesity 1 Klatskin Tumor 1 Duodenal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Bites and Stings 1

Interventions

Pancreaticojejunostomy 4 Endoscopic Mucosal Resection 3 Octreotide 2 obeticholic acid 1 fludarabine 1 apixaban 1 aldesleukin 1 X-Rays 1 Ursodeoxycholic Acid 1 Tranexamic Acid 1 Tissue Adhesives 1 Tea 1 Surgical Procedures, Operative 1 Stents 1 Specimen Handling 1 Sodium Chloride 1 Rivaroxaban 1 Radiotherapy 1 Radiosurgery 1 Phantoms, Imaging 1 Pantoprazole 1 Nutritional Status 1 Nutrition Therapy 1 Irinotecan 1 Iopamidol 1 Hydromorphone 1 Hydrocortisone 1 High-Energy Shock Waves 1 Epinephrine 1 Enteral Nutrition 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06630910 2024-10-08

whipple

Theodor Bilharz Research Institute

Phase 4 Completed

Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡